The Synthetic Human Genome (SynHG) Project, launched on the 25th anniversary of the mapping of the human genome, is being ...

The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – has been ...

The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

Success in this area means ensuring the right therapy reaches the patient in a form that is stable, effective, and ready for ...

At Longeveron, Dr. Joshua Hare and his team are working on an Alzheimer’s treatment using human-derived bone marrow ...

To close the innovation-access gap, there is a desperate need for an infrastructure rooted in trust. That means complementing ...

Following a pre-Congress press briefing and data presented onsite at ASCO 2025 itself, pharmaphorum spoke with Dr Victoria ...

The FDA has launched a review of clinical trials that plan to send American citizens' living cells to 'hostile' countries – ...

An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first ...

As the CEO of ProofPilot, Chris Venezia has a track record of success with more than 18 years of strong leadership in product ...

Don’t miss the return of the Translational Digital Pathology & AI Summit, uniting 60+ leading biopharma pioneers driving the ...

The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this ...